To provide for quality assurance of COVID-19 reimbursements and reporting.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 13, 2021)
This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test has been approved, cleared, or authorized by the Food and Drug Administration.
Further, the Centers for Disease Control and Prevention must exclude from its official COVID-19 case and death counts any person who tested positive and requested federal reimbursement without the required documentation.
Additionally, any person who knowingly reports a false diagnosis of COVID-19 is subject to criminal fines and imprisonment for not more than 10 years.
What just happenedMar 5, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Who’s behind it
- Introduced in HouseJan 13, 2021
- Mar 5, 2021Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Crime and Federal Government Surveillance Subcommittee - Feb 2, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 13, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Jan 13, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 13, 2021IntroReferralIntro-H
Introduced in House
- Jan 13, 2021IntroReferral1000
Introduced in House